Cited by 163Herpesvirus Infections and TreatmentsAcute Ischemic Stroke ManagementCytomegalovirus and herpesvirus research

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Risk of Stroke Following Herpes Zoster: A Self-Controlled Case-Series Study

Open access

Abstract

BACKGROUND: Herpes zoster is common and vaccine preventable. Stroke risk may be increased following zoster, but evidence is sparse and could be explained by differences between people with and without zoster. Our objective was to determine if stroke risk is increased following zoster. METHODS: Within-person comparisons were undertaken using the self-controlled case-series method and data from the UK Clinical Practice Research Datalink (1987-2012). Participants had a first-ever diagnosis of zoster and stroke within the study period. Stroke incidence in periods following zoster was compared with incidence in other time periods. Age-adjusted incidence ratios (IRs) and 95% confidence intervals (CIs) were calculated. RESULTS: A total of 6584 individuals were included. Stroke rate was increased following zoster compared with the baseline unexposed period, then gradually reduced over 6 months: weeks 1-4 (age-adjusted IR, 1.63; 95% CI, 1.32-2.02), weeks 5-12 (IR, 1.42; 95% CI, 1.21-1.68), and weeks 13-26 (IR, 1.23; 95% CI, 1.07-1.42), with no increase thereafter. A stronger effect was observed for individuals with zoster ophthalmicus, rising to a >3-fold rate 5-12 weeks after zoster. Oral antivirals were given to 55% of individuals: IRs for stroke were lower among those receiving antivirals compared with those not treated, suggesting a protective effect. CONCLUSIONS: We have established an increased stroke rate within 6 months following zoster. Findings have implications for zoster vaccination programs, which may reduce stroke risk following zoster. The low antiviral prescribing rate needs to be improved; our data suggest that antiviral therapy may lead to a reduced stroke risk following zoster.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciu098

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 28

  1. 2008, Inflammation, C-reactive protein, and atherothrombosis, J Periodontol, 79, 1544
  2. 2008, Acute ischaemic stroke and infection: recent and emerging concepts, Lancet Neurol, 7, 341, 10.1016/S1474-4422(08)70061-9 · DOI
  3. 2009, Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review, Lancet Infect Dis, 9, 601, 10.1016/S1473-3099(09)70233-6 · DOI
  4. 2007, A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction, Mayo Clin Proc, 82, 1341, 10.4065/82.11.1341 · DOI
  5. 2010, The impact of herpes zoster and post-herpetic neuralgia on quality-of-life, BMC Med, 8, 37, 10.1186/1741-7015-8-37 · DOI
  6. 2001, Epidemiology of varicella zoster virus infection in Canada and the United Kingdom, Epidemiol Infect, 127, 305, 10.1017/S0950268801005921 · DOI
  7. 2009, Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment, Lancet Neurol, 8, 731, 10.1016/S1474-4422(09)70134-6 · DOI
  8. 2002, Images in clinical medicine. Herpes zoster ophthalmicus followed by contralateral hemiparesis, N Engl J Med, 346, 1127, 10.1056/NEJMicm010341 · DOI
  9. 1993, Cerebral infarction following thoracic herpes zoster, Australas J Dermatol, 34, 113, 10.1111/j.1440-0960.1993.tb00877.x · DOI
  10. 2009, Increased risk of stroke after a herpes zoster attack: a population-based follow-up study, Stroke, 40, 3443, 10.1161/STROKEAHA.109.562017 · DOI
  11. 2010, Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study, Neurology, 74, 792, 10.1212/WNL.0b013e3181d31e5c · DOI
  12. 2010, Does herpes zoster ophthalmicus increase the risk of stroke?, Neurology, 74, 788, 10.1212/WNL.0b013e3181d4f1fe · DOI
  13. 2004, MMR vaccination and pervasive developmental disorders: a case-control study, Lancet, 364, 963, 10.1016/S0140-6736(04)17020-7 · DOI · Paper page
  14. 2004, Risk of myocardial infarction and stroke after acute infection or vaccination, N Engl J Med, 351, 2611, 10.1056/NEJMoa041747 · DOI
  15. 2006, Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting, Lancet, 367, 1075, 10.1016/S0140-6736(06)68474-2 · DOI
  16. 1995, Relative incidence estimation from case series for vaccine safety evaluation, Biometrics, 51, 228, 10.2307/2533328 · DOI
  17. 2005, The relationship between time since registration and measured incidence rates in the General Practice Research Database, Pharmacoepidemiol Drug Saf, 14, 443, 10.1002/pds.1115 · DOI
  18. 2010, Invasive dental treatment and risk for vascular events: a self-controlled case series, Ann Intern Med, 153, 499, 10.7326/0003-4819-153-8-201010190-00006 · DOI
  19. 2003, Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?, Thorax, 58, 835, 10.1136/thorax.58.10.835 · DOI
  20. 2013, The short- and long-term risk of stroke after herpes zoster—a nationwide population-based cohort study, PLoS One, 8, e69156, 10.1371/journal.pone.0069156 · DOI
  21. 2010, Inflammation, innate immunity and blood coagulation, Hamostaseologie, 30, 5, 10.1055/s-0037-1617146 · DOI
  22. 2012, Prescription of antiviral therapy after herpes zoster in general practice: who receives therapy?, Br J Gen Pract, 62, e808, 10.3399/bjgp12X659277 · DOI
  23. 1995, Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group, Ann Intern Med, 123, 89, 10.7326/0003-4819-123-2-199507150-00002 · DOI
  24. 2004, Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice, Neurology, 62, 563, 10.1212/01.WNL.0000110312.36809.7F · DOI
  25. 2001, Diagnosis and initial management of stroke and transient ischemic attack across UK health regions from 1992 to 1996: experience of a national primary care database, Stroke, 32, 1085, 10.1161/01.STR.32.5.1085 · DOI
  26. 2007, Clinical diagnosis of herpes zoster in family practice, Ann Fam Med, 5, 305, 10.1370/afm.707 · DOI
  27. 1995, The incidence of herpes zoster, Arch Intern Med, 155, 1605, 10.1001/archinte.1995.00430150071008 · DOI
  28. 2011, Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?, Am J Epidemiol, 174, 1054, 10.1093/aje/kwr206 · DOI

Cited by

Sorted by citations

Metadata

Authors
Langan, S. M., Minassian, C., Smeeth, L., & Thomas, S. L.
Affiliations
London School of Hygiene & Tropical Medicine (GB)
Corresponding author
Langan, Sinéad M.
Venue
Clinical Infectious Diseases
Published
2014-04-02
Volume
58
Issue
11
Pages
1497-1503
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2102440817
Cited by
163
References
2
Citations by year
2026: 10 · 2025: 11 · 2024: 11 · 2023: 8 · 2022: 10 · 2021: 6 · 2020: 12 · 2019: 12 · 2018: 13 · 2017: 23 · 2016: 16 · 2015: 22 · 2014: 8
FWCI
15.59
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Clinical Infectious Diseases (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Funders
  • Wellcome Trust (098504/Z/12/Z, 098504)
  • National Institute for Health and Care Research (NIHR/CS/010/014, CDF-2010-03-32)
  • Medical Research Council (MR/K006584/1)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Keywords
herpes zoster, stroke, herpes zoster ophthalmicus, antiviral therapy, stroke risk, herpes zoster vaccination, incidence ratio
MeSH terms
Age Factors, Aged, Aged, 80 and over, Antiviral Agents, Female, United Kingdom, Herpes Zoster, Humans, Male, Time Factors, Incidence, Risk Assessment, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review